Home>
US Stocks>
Adaptive Biotechnologies

Adaptive Biotechnologies share price today

(ADPT)

Adaptive Biotechnologies share price is $6.39 & ₹544.42 as on 25 Dec 2024, 2.30 'hrs' IST

$6.39

▲

0.07

(1.11%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Adaptive Biotechnologies share price in Dollar and Rupees. Guide to invest in Adaptive Biotechnologies from India. Also see the sentimental analysis on Indian investors investing in Adaptive Biotechnologies. Get details on the Indian mutual funds that are investing in Adaptive Biotechnologies. Get Analyst recommendations and forecasts along with all the Adaptive Biotechnologies's financials.

Adaptive Biotechnologies share price movements

Today's Low: $6.20
Today's High: $6.68
$6.39
3.05%
Downside
Day's Volatility :7.2%
Upside
4.28%
52 Weeks Low: $2.28
52 Weeks High: $7.07
$6.39
64.32%
Downside
52 Weeks Volatility :67.74%
Upside
9.57%

Adaptive Biotechnologies Returns

Period	Adaptive Biotechnologies Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	30.41%	-9.0%	0.0%
6 Months	84.68%	-4.6%	0.0%
1 Year	25.05%	3.0%	0.0%
3 Years	-76.23%	0.0%	-21.1%

Adaptive Biotechnologies Key Statistics

in dollars & INR

Previous Close	$6.32
Open	$6.33
Today's High	$6.6759
Today's Low	$6.195
Market Capitalization	$943.0M
Today's Volume	$410.8K
52 Week High	$7.0665
52 Week Low	$2.28
Revenue TTM	$177.3M
EBITDA	$-146.9M
Earnings Per Share (EPS)	$-1.34
Profit Margin	-110.13%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-66.76%

How to invest in Adaptive Biotechnologies from India?

It is very easy for Indian residents to invest directly in Adaptive Biotechnologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Adaptive Biotechnologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Adaptive Biotechnologies or ADPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Adaptive Biotechnologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Adaptive Biotechnologies shares which would translate to 0.133 fractional shares of Adaptive Biotechnologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Adaptive Biotechnologies, in just a few clicks!

Returns in Adaptive Biotechnologies for Indian investors in Rupees

Investment Value

₹1,00,000

Adaptive Biotechnologies investment value today

Current value as on today

₹1,27,288

Returns

₹27,288

(+27.29%)

Returns from Adaptive Biotechnologies Stock

₹25,049 (+25.05%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Adaptive Biotechnologies

140%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Adaptive Biotechnologies on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 140% more investors are searching Adaptive Biotechnologies in the last 30 days versus the previous period.

Global Institutional Holdings in Adaptive Biotechnologies

Viking Global Investors LP
20.32%
Rubric Capital Management LP
9.76%
BlackRock Inc
7.90%
ARK Investment Management LLC
7.86%
Vanguard Group Inc
7.21%
Millennium Management LLC
6.37%

Analyst Recommendation on Adaptive Biotechnologies

Buy

78%Buy

21%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Adaptive Biotechnologies(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Adaptive Biotechnologies

What analysts predicted

Upside of 18.67%

Current:

$6.39

Target:

$7.58

Insights on Adaptive Biotechnologies

Price Movement
In the last 1 month, ADPT stock has moved up by 12.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 41.87M → 46.43M (in $), with an average increase of 5.0% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -69.44M → -32.07M (in $), with an average increase of 31.0% per quarter
ADPT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 0.7%
ADPT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 102.7%
Price to Sales
ForADPT every $1 of sales, investors are willing to pay $5.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Adaptive Biotechnologies Technicals Summary

Sell

Neutral

Buy

Adaptive Biotechnologies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Adaptive Biotechnologies Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Adaptive Biotechnologies Corp	12.5%	84.68%	25.05%	-76.23%	-77.93%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Adaptive Biotechnologies Corp	NA	NA	0.0	-1.11	-0.67	-0.16	NA	1.52
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Adaptive Biotechnologies Corp	Buy	$943.0M	-77.93%	NA	-110.13%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Adaptive Biotechnologies

we are a commercial-stage, biotechnology organization located in the hot biotech locations of seattle, washington and south san francisco, ca. our world class scientists have invented a patent-pending technology that combines advances in high-throughput sequencing with state-of-the-art computer infrastructure to provide an in-depth analysis of the t- and b-cell repertoire, a specific and important part of the immune system. this information is driving the r&d community to support the fights against cancer, auto-immune disease, and much, much more. we're often asked to describe our company culture. it is very easy ... we're a hard working group of top-notch individuals who are passionate about wanting to make a difference in the world. we know our employees are our most valuable asset, and every employee’s contribution is appreciated. open communication and collaboration are always encouraged in every interaction throughout the organization. we have high expectations of ourselves, and

Organization	Adaptive Biotechnologies
Employees	709
CEO	Mr. Chad M. Robins M.B.A.
Industry	Commercial Services

Management People of Adaptive Biotechnologies

Name	Title
Mr. Chad M. Robins M.B.A.	Co-Founder, CEO & Chairman
Ms. Julie Rubinstein	President & COO
Dr. Harlan S. Robins Ph.D.	Co-Founder & Chief Scientific Officer
Dr. Sharon Benzeno Ph.D.	Chief Commercial Officer of Immune Medicine
Mr. Christopher Carlson Ph.D.	Founder
Mr. Kyle Piskel	VP, CFO & Principal Accounting Officer
Ms. Karina Calzadilla	Vice President of Investor Relations
Mr. Francis T. Lo	Chief People Officer
Ms. Susan Bobulsky	Chief Commercial Officer of MRD
Ms. Mary Pat Lancelotta	Senior Vice President of MRD BioPharma

Important FAQs about investing in Adaptive Biotechnologies from India :

What is Adaptive Biotechnologies share price today?

Adaptive Biotechnologies share price today stands at $6.39, Open: $6.33 ; Previous Close: $6.32 ; High: $6.68 ; Low: $6.20 ; 52 Week High: $7.07 ; 52 Week Low: $2.28. The stock opens at $6.33, after a previous close of $6.32. The stock reached a daily high of $6.68 and a low of $6.20, with a 52-week high of $7.07 and a 52-week low of $2.28.

Can Indians buy Adaptive Biotechnologies shares?

Yes, Indians can invest in the Adaptive Biotechnologies (ADPT) from India.

With INDmoney, you can buy Adaptive Biotechnologies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Adaptive Biotechnologies at zero transaction cost.

How can I buy Adaptive Biotechnologies shares from India?

It is very easy to buy Adaptive Biotechnologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Adaptive Biotechnologies be purchased?

Yes, you can buy fractional shares of Adaptive Biotechnologies with INDmoney app.

What are the documents required to start investing in Adaptive Biotechnologies stocks?

To start investing in Adaptive Biotechnologies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.